Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 2
1985 1
1986 4
1987 2
1988 1
1989 1
1991 1
1992 1
1993 1
1996 2
1998 1
1999 1
2000 2
2001 4
2003 3
2004 3
2005 2
2006 6
2007 3
2008 4
2009 2
2010 4
2011 2
2012 3
2013 4
2014 2
2015 3
2016 3
2017 2
2018 2
2019 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
PARP-1 deregulation in multiple sclerosis.
Meira M, Sievers C, Hoffmann F, Bodmer H, Derfuss T, Kuhle J, Haghikia A, Kappos L, Lindberg RL. Meira M, et al. Among authors: lindberg rl. Mult Scler J Exp Transl Clin. 2019 Dec 16;5(4):2055217319894604. doi: 10.1177/2055217319894604. eCollection 2019 Oct-Dec. Mult Scler J Exp Transl Clin. 2019. PMID: 31897308 Free PMC article.
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Rasenack M, Rychen J, Andelova M, Naegelin Y, Stippich C, Kappos L, Lindberg RL, Sprenger T, Derfuss T. Rasenack M, et al. Among authors: lindberg rl. PLoS One. 2016 Jan 6;11(1):e0146190. doi: 10.1371/journal.pone.0146190. eCollection 2016. PLoS One. 2016. PMID: 26734938 Free PMC article.
MiR-126: a novel route for natalizumab action?
Meira M, Sievers C, Hoffmann F, Derfuss T, Kuhle J, Kappos L, Lindberg RL. Meira M, et al. Among authors: lindberg rl. Mult Scler. 2014 Sep;20(10):1363-70. doi: 10.1177/1352458514524998. Epub 2014 Mar 5. Mult Scler. 2014. PMID: 24598267
74 results